Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why
Nomura has raised its FY27/FY28 sales estimates by around 2.5%, EBITDA estimates by 9% and PAT estimates by 13%, reflecting the stronger momentum and upgraded guidance. from NDTV Profit - Latest https://ift.tt/6EPGsuK Nomura has raised its FY27/FY28 sales estimates by around 2.5%, EBITDA estimates by 9% and PAT estimates by 13%, reflecting the stronger momentum and upgraded guidance.